Genomic loss of heterozygosity and survival in the REAL3 trial.
Saved in:
| Title: | Genomic loss of heterozygosity and survival in the REAL3 trial. |
|---|---|
| Authors: | Smyth EC; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Cafferkey C; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Loehr A; Clovis Oncology, San Francisco, CA, United States of America., Waddell T; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom.; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom., Begum R; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Peckitt C; Department of Clinical Research & Development, Royal Marsden Hospital, London & Sutton, United Kingdom., Harding TC; Clovis Oncology, San Francisco, CA, United States of America., Nguyen M; Clovis Oncology, San Francisco, CA, United States of America., Okines AF; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Raponi M; Clovis Oncology, San Francisco, CA, United States of America., Rao S; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Watkins D; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Starling N; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Middleton GW; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Wadsley J; Department of Medical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Mansoor W; Current affiliation: Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom., Crosby T; Department of Clinical Oncology, Velindre Hospital, Cardiff, Wales, United Kingdom., Wotherspoon A; Department of Histopathology, Royal Marsden Hospital, London & Surrey, United Kingdom., Chau I; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom., Cunningham D; Department of Gastrointestinal Oncology and Lymphoma, Royal Marsden Hospital, London & Sutton, United Kingdom. |
| Source: | Oncotarget [Oncotarget] 2018 Nov 30; Vol. 9 (94), pp. 36654-36665. Date of Electronic Publication: 2018 Nov 30 (Print Publication: 2018). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
